###begin article-title 0
ATR-dependent pathways control hEXO1 stability in response to stalled forks
###end article-title 0
###begin p 1
Present address: Said Moselhy, Department of Biochemistry, Faculty of Science, Aim-Shams University, Abbassia, Cairo, Egypt.
###end p 1
###begin p 2
###xml 0 16 0 16 <!--CREATIVE COMMONS-->
CREATIVE COMMONSThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 2
###begin p 3
###xml 1084 1087 1084 1087 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 1157 1160 1157 1160 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 105 110 <span type="species:ncbi:9606">human</span>
Nucleases play important roles in DNA synthesis, recombination and repair. We have previously shown that human exonuclease 1 (hEXO1) is phosphorylated in response to agents stalling DNA replication and that hEXO1 consequently undergoes ubiquitination and degradation in a proteasome-dependent manner. In the present study, we have addressed the identity of the pathway transducing stalled-replication signals to hEXO1. Using chemical inhibitors, RNA interference, ATM- and ATR-deficient cell lines we have concluded that hEXO1 phosphorylation is ATR-dependent. By means of mass spectrometry, we have identified the sites of phosphorylation in hEXO1 in undamaged cells and in cells treated with hydroxyurea (HU). hEXO1 is phosphorylated at nine basal sites and three additional sites are induced by HU treatment. Analysis of single- and multiple-point mutants revealed that mutation to Ala of the three HU-induced sites of phosphorylation partially rescued HU-dependent degradation of hEXO1 and additionally stabilized the protein in non-treated cells. We have raised an antibody to pS714, an HU-induced site of the S/T-Q type, and we provide evidence that S714 is phosphorylated upon HU but not IR treatment. The antibody may be a useful tool to monitor signal transduction events triggered by stalled DNA replication.
###end p 3
###begin title 4
INTRODUCTION
###end title 4
###begin p 5
###xml 101 126 101 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schizosaccharomyces pombe</italic>
###xml 128 129 128 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 148 161 148 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pombe Exo1</italic>
###xml 315 316 315 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 352 376 352 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 385 413 385 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila melanogaster EXO1</italic>
###xml 458 459 458 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 460 461 460 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 622 623 622 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 644 648 644 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EXO1</italic>
###xml 724 725 724 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 726 727 726 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 858 871 858 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. cerevisiae</italic>
###xml 916 921 916 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rad27</italic>
###xml 930 931 930 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 932 933 932 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 1036 1037 1036 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 1038 1039 1038 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 1312 1313 1312 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 87 100 <span type="species:ncbi:4896">fission yeast</span>
###xml 101 126 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
###xml 148 156 <span type="species:ncbi:4896">S. pombe</span>
###xml 352 376 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 385 408 <span type="species:ncbi:7227">Drosophila melanogaster</span>
###xml 464 469 <span type="species:ncbi:10090">Mouse</span>
###xml 630 635 <span type="species:ncbi:9606">human</span>
###xml 705 710 <span type="species:ncbi:4932">yeast</span>
###xml 743 748 <span type="species:ncbi:9606">human</span>
###xml 815 820 <span type="species:ncbi:4932">yeast</span>
###xml 858 871 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 910 915 <span type="species:ncbi:4932">yeast</span>
###xml 939 945 <span type="species:ncbi:9606">humans</span>
###xml 1182 1187 <span type="species:ncbi:10090">mouse</span>
Exonuclease 1 is a DNA repair nuclease of the Rad2 family originally identified in the fission yeast Schizosaccharomyces pombe (1). The activity of S. pombe Exo1 gene product is induced about 5-fold just prior to meiosis, which led to the suggestion that Exo1 might be involved in meiotic homologous recombination (1). Transcriptional induction of the Saccharomyces cerevisiae and the Drosophila melanogaster EXO1 gene during meiosis has also been reported (2,3). Mouse Exo1 was found predominantly expressed in testis and the spleen, consistent with roles in processes specific to germ cell maturation and hematopoiesis (4). The human homolog EXO1 gene encodes a protein bearing only 27% identity to its yeast counterpart (5,6). Nonetheless, human exonuclease 1 (hEXO1) was shown to be functionally similar to the yeast protein by its ability to complement S. cerevisiae Exo1 and the mutator phenotype of the yeast rad27 mutant (5,7). In humans, two isoforms (hEXO1a and hEXO1b) have been described to arise from alternative splicing (5,8), though no functional differences between the two isoforms have been reported. The expression of hEXO1 reflects the pattern reported for the mouse, with high levels in testis, thymus and colon and slightly lower expression in small intestine, placenta, spleen and ovary (5).
###end p 5
###begin p 6
###xml 273 274 273 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
EXO1 catalyzes the removal of mononucleotides from the 5' end of the DNA duplex, showing a strong preference for blunt-ended, 5' recessed termini and DNA nicks. It can also degrade exonucleolytically single-stranded DNA, although less efficiently than double-stranded DNA (9,10). Moreover, hEXO1 displays a 5' ssDNA-flap-specific endonuclease activity but does not possess endonuclease activity at bubble-like structures (10).
###end p 6
###begin p 7
###xml 3 16 3 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. cerevisiae</italic>
###xml 138 139 138 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 225 233 225 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pombe</italic>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 542 543 542 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 555 557 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 712 714 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 858 860 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 879 881 879 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 961 962 961 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 1001 1006 1001 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17 B18 B19 B20">17&#8211;20</xref>
###xml 1223 1225 1223 1225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1254 1255 1254 1255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 1292 1294 1292 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1398 1400 1398 1400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1413 1415 1413 1415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 1530 1532 1530 1532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 1689 1691 1689 1691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 1767 1770 1767 1770 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">418</sub>
###xml 1773 1776 1773 1776 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">421</sub>
###xml 1868 1870 1868 1870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 3 16 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 225 233 <span type="species:ncbi:4896">S. pombe</span>
###xml 373 378 <span type="species:ncbi:9606">human</span>
###xml 504 509 <span type="species:ncbi:4932">yeast</span>
###xml 627 632 <span type="species:ncbi:4932">yeast</span>
###xml 740 745 <span type="species:ncbi:9606">human</span>
###xml 1175 1180 <span type="species:ncbi:4932">yeast</span>
###xml 1334 1339 <span type="species:ncbi:9606">human</span>
In S. cerevisiae, EXO1 was shown to participate in meiotic crossing over as well as in the processing of double-strand breaks (DSB) ends (2). An additional role in mutation avoidance and mismatch correction was described for S. pombe Exo1 (11). Mismatch repair (MMR) is a mechanism reducing the rate of somatic microsatellite polymorphism and it is disabled in a number of human cancers (12). The involvement of Exo1 in MMR was confirmed by studies demonstrating physical and genetic interaction between yeast Exo1 and the MMR proteins Msh2 (6) and Mlh1 (13). Furthermore, an independent study confirmed the structural role of yeast Exo1 in the stabilization of the multiprotein complex containing MMR proteins (14). Studies conducted with human recombinant proteins or HeLa cells extracts confirmed the interaction between hEXO1 and the MMR proteins hMSH2 (15) and hMLH1/hPMS2 (16). The functional role of hEXO1 in MMR was addressed in complementation assays (5) as well as in reconstituted systems (17-20). Taken together, the evidence provided by these studies pointed to hEXO1 as the most likely candidate for the excision step during MMR in mammals. In addition to MMR, yeast Exo1 was shown to participate to mitotic (21) and meiotic recombination (2) and to end-resection at telomeres (22). The physical interaction observed in human cells between hEXO1 and the Werner Syndrome helicase WRN (23) and RECQ1 (24) further pointed to a role for hEXO1 in the resolution of DNA intermediates that are formed during recombination (25). In ectopic expression studies, hEXO1 was shown to interact with PCNA via its C-terminal region and the two proteins co-localized at DNA replication foci (26). Proper nuclear localization of hEXO was shown to depend on the sequence K418RPR421, which exhibits strong homology to other monopartite nuclear localization sequences (NLS) (27).
###end p 7
###begin p 8
###xml 71 74 71 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 206 209 206 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 391 393 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 503 505 503 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 418 422 <span type="species:ncbi:10090">mice</span>
The importance of exonuclease 1 is underscored by the phenotype of Exo1-/- mice that displayed reduced survival, sterility and increased susceptibility to the development of lymphomas (28). Analysis of Exo1-/- cells revealed specific defects in MMR leading to elevated microsatellite instability, increased mutation rate at the Hprt locus and abnormal spindle structures in metaphase cells (28). Moreover, Exo1 mutant mice displayed altered somatic hypermutation and reduced class switch recombination (29).
###end p 8
###begin p 9
###xml 63 65 63 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 66 68 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
Consistent with its proposed role at sites of DNA replication (30,31), we have previously shown that the hEXO1 protein is selectively destabilized in response to fork arrest. We reported the rapid degradation of hEXO1 to depend on ubiquitin-mediated proteasome pathways and to be facilitated by phosphorylation (32). In the present study, we have examined the pathway transducing the fork-arrest signal to hEXO1 and we have identified ATR as the responsible kinase. Moreover, we have localized the sites of phosphorylation in hEXO1 and assessed their role in the stability of the protein. Finally, we have generated and characterized an antibody to one of the fork arrest-induced sites of phosphorylation in hEXO1 that would represent a useful tool in studies addressing DNA replication fork stalling.
###end p 9
###begin title 10
MATERIALS AND METHODS
###end title 10
###begin title 11
Antibodies and chemicals
###end title 11
###begin p 12
###xml 82 84 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 218 221 218 221 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">345</sub>
###xml 230 232 230 232 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">68</sub>
###xml 243 245 243 245 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sub>
###xml 324 328 324 328 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1981</sub>
###xml 793 798 <span type="species:ncbi:10090">mouse</span>
###xml 808 814 <span type="species:ncbi:9986">rabbit</span>
###xml 944 948 <span type="species:ncbi:9925">goat</span>
The polyclonal antibody F-15 to the N-terminus of hEXO1 was previously described (32). A monoclonal antibody to full-length EXO1 (Ab-4, clone 266) was purchased from NeoMarkers (Fremont, CA, USA). Antibodies to CHK1-pS345, CHK2-pT68 and p53-pS15 were from Cell Signaling Technology (Beverly, MA, USA). The antibody to ATM-pS1981 was from Rockland (Gilbertsville, PA, USA). Antibodies to ATM and ATR were from Gentex (San Antonio, TX, USA) and Calbiochem (San Diego, CA, USA), respectively. Antibodies to TFIIH (sc-293) and MSH6 (clone 44, G70220) were from Santa Cruz Biotechnology (Santa Cruz, CA, USA) and BD Transduction Laboratories (San Jose, CA, USA), respectively. The Omni-probe antibody (sc-499) used to detect Omni-tagged hEXO1 was from Santa Cruz Biotechnology. HRP-conjugated anti-mouse and anti-rabbit secondary antibodies were obtained from Amersham-Biosciences/GE-Healthcare (Otelfingen, Switzerland), whereas the secondary anti-goat was obtained from Santa Cruz Biotechnology.
###end p 12
###begin p 13
###xml 32 35 32 35 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 255 262 <span type="species:ncbi:9986">rabbits</span>
The antibody to phosphorylated S714 in hEXO1 was raised using the peptide CNIKLLDpSQSDQT, where pS represents phospho-Serine (Eurogentec, Seraing, Belgium). The HPLC purified peptide was coupled to Keyhole Limpet Hemocyanin (KLH) and used to immunize two rabbits. The resulting sera were affinity purified by two consecutive chromatography steps over phosphopeptide and non-phosphopeptide columns. The phospho-specific antibody was eluted with 0.1 M glycine-HCl pH 2.5 and neutralized with 1 M Tris-HCl pH 8.0.
###end p 13
###begin p 14
Hydroxyurea (HU) and caffeine were obtained from Sigma (St. Louis, MO, USA) and dissolved in water. KU-55933 was kindly provided by Kudos Pharmaceuticals (Cambridge, UK) and dissolved in DMSO. MG132 was purchased from Calbiochem and dissolved in DMSO.
###end p 14
###begin title 15
Expression vectors for wild type (wt) and mutant hEXO1
###end title 15
###begin p 16
###xml 163 166 163 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#169;</sup>
The protein referred as hEXO1 throughout this study is the isoform b. An expression vector for wt-hEXO1 was created by subcloning full-length hEXO1 in pcDNA3.1-His(c) (Invitrogen, Carlsbad, CA, USA) 3' to a His-tag that is specifically recognized by the Omni-probe antibody. Single- and multiple-hEXO1 mutants of the sites of phosphorylation (Ser/Thr > Ala) were generated with the QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA, USA) using wt-hEXO1 as template. The overlapping oligonucleotides employed were the following:
###end p 16
###begin p 17
###xml 1 4 1 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">454</sub>
S454 > A forward: 5'-GCAATAAATCATTGGCCTTTTCTGAAGTG-3'
###end p 17
###begin p 18
###xml 1 4 1 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">454</sub>
S454 > A reverse: 5'-CACTTCAGAAAAGCCCAATGATTTATTGC-3'
###end p 18
###begin p 19
###xml 1 4 1 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">621</sub>
T621 > A forward: 5'-GAGATTTTTCAAGAGCGCCGAGCCCCTCTCC-3'
###end p 19
###begin p 20
###xml 1 4 1 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">621</sub>
T621 > A reverse: 5'-GGAGAGGGGCTCGGCGCTCTTGAAAAATCTC-3'
###end p 20
###begin p 21
###xml 1 4 1 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
S714 > forward: 5'-GCAATATTAAGTTACTTGACGATCAAAGTGACCAGACC-3'
###end p 21
###begin p 22
###xml 1 4 1 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
S714 > reverse: 5'-CGTTATAATTCAATGAACTGCTAGTTTCACTGGTCTGG-3'
###end p 22
###begin p 23
###xml 1 4 1 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">674</sub>
S674 > A forward: 5'-GGCATGTTCTGCACAGTCCCAGGAAAG-3'
###end p 23
###begin p 24
###xml 1 4 1 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">674</sub>
S674 > A reverse: 5'-CTTTCCTGGGACTGTGCAGAACATGCC-3'
###end p 24
###begin p 25
###xml 1 4 1 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">676</sub>
S676 > A forward: 5'-GTTCTGCACAGGCCCAGGAAAGTGG-3'
###end p 25
###begin p 26
###xml 1 4 1 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">676</sub>
S676 > A reverse: 5'-CCACTTTCCTGGGCCTGTGAAGAAC-3'
###end p 26
###begin p 27
###xml 1 4 1 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">693</sub>
S693 > A forward: 5'-GCATCAAAGCTTGCTCAGTGCTCTAG-3'
###end p 27
###begin p 28
###xml 1 4 1 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">693</sub>
S693 > A reverse: 5'-CTAGAGCACTGAGCAAGCTTTGATGC-3'
###end p 28
###begin p 29
All single and multiple mutations were verified by DNA sequencing.
###end p 29
###begin title 30
Cell culture and transfections
###end title 30
###begin p 31
###xml 492 494 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 31 36 <span type="species:ncbi:10090">mouse</span>
###xml 172 176 <span type="species:ncbi:9913">calf</span>
HEK-293, HEK-293T, HeLa, U2OS, mouse embryonal fibroblast (MEF) and NIH3T3 cells were maintained in DMEM (OmniLab, Mettmenstetten, Switzerland) supplemented with 10% fetal calf serum (FCS) (Life technologies, Rockville, MD, USA), penicillin (100 U/ml) and streptomycin (100 mug/ml). The ATM-deficient (AT) fibroblasts AT22IJE-T and the matched line complemented with an ATM minigene (AT + ATM) were kindly provided by Y. Shiloh (Tel Aviv University, Israel) and were maintained as described (33). ATR-Seckel cells were kindly provided by M. O'Driscoll and P. Jeggo (University of Sussex, UK) and were maintained in RPMI (OmniLab, Mettmenstetten, Switzerland) supplemented with 15% FCS, penicillin (100 units/ml) and streptomycin (100 mug/ml).
###end p 31
###begin p 32
Transient transfections were performed in 6 cm cell culture dishes using 0.5 mug expression vector for wt-EXO1 or Ala-point mutants and the FuGENE-6(R) transfection reagent (Roche, Basel, Switzerland). Eight hours upon transfection cells were either left untreated or treated with HU for 24 h and harvested 32 h post-transfection.
###end p 32
###begin p 33
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
To create stable cell lines expressing shRNA for ATM or ATR, the constructs described in Ref. (34) were used. HEK-293T cells were transfected either with empty vector (EV) or with shRNA specific to ATM or ATR. Cells underwent selection with 10 mug/ml puromycin for 3 weeks. Downregulation of specific target genes was monitored by western blot analysis.
###end p 33
###begin p 34
Irradiation of cell was performed using a Faxitron(R) Cabinet X-ray system, model 43855D (Faxitron X-ray Corp., Wheeling, IL, USA).
###end p 34
###begin title 35
Western blotting and immunoprecipitation
###end title 35
###begin p 36
Cellular proteins were extracted using ice-cold lysis buffer (50 mM Tris-HCl pH 7.5, 120 mM NaCl, 20 mM NaF, 1 mM EDTA, 6 mM EGTA, 15 mM Na-pyrophosphate, 0.5 mM Na-orthovanadate, 1 mM benzamidine, 0.1 mM phenylmethylsulfonyl fluoride and 1% nonidet P-40). Protein concentration was determined using the Bio-Rad Protein Assay Reagent (Bio-Rad, Hercules, CA, USA). Detection of proteins by western blot analysis was performed following separation of whole cell extracts (50 mug) on 8% SDS-PAGE. To detect ATM or ATR in whole cell extracts, 6% SDS-PAGE was used. Proteins were transferred to polyvinylidene difluoride (PVDF) (Amersham Biosciences GE-Healthcare, Otelfingen, Switzerland), probed with appropriate antibodies and immune complexes were revealed using the enhanced chemiluminescence system (Amersham Biosciences GE-Healthcare, Otelfingen, Switzerland).
###end p 36
###begin p 37
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
Immunoprecipitation of hEXO1 was carried out with polyclonal antibody F-15, as previously described (32), using HEK-293 (2 mg), HEK-293T (2 mg), HeLa (5 mg), U2OS (7 mg), MEF (6 mg) or NIH3T3 (9 mg) total cell extracts. The immunoprecipitated proteins were revealed by western blot using monoclonal Ab-4 antibody.
###end p 37
###begin title 38
Mass spectrometric analysis
###end title 38
###begin p 39
###xml 1058 1060 1043 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 2150 2152 2120 2122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
HEK-293 cells were transfected with an expression vector for wt-hEXO1 using Metafectene(R) (Biontex, Planegg, Germany) as transfection reagent. Twenty-four hours upon transfection, cells were either left untreated or treated with HU for 24 h and were harvested 48 h post-transfection. Using the Omni-probe antibody, hEXO1 was immunoprecipitated from 12 mg of cell extracts, for 3 h at 4degreesC. The antibody was captured on protein G-agarose beads that were subsequently washed twice with TNET buffer (50 mM Tris-HCl pH 7.5, 140 mM NaCl, 5 mM EDTA and 1% Triton X-100) and twice with TNE buffer (50 mM Tris-HCl pH 7.5, 140 mM NaCl and 5 mM EDTA) before boiling in an equal volume of 2x Laemmli-SDS sample buffer. Samples were alkylated with iodoacetamide (55 mM) for 45 min in the dark. Proteins were subjected to electrophoresis on 8% SDS-PAGE and stained with Coomasie Brilliant Blue. Bands corresponding to Omni-hEXO1 were excised and digested with 1 mug trypsin (Promega, Madison, WI, USA) in 50 mM ammonium bicarbonate (pH 8.0) at 37degreesC for 16 h (35). The resulting peptides were analyzed by capillary liquid chromatography-tandem mass spectrometry (LC-MS/MS) using a Magic C18 100 mum x 10 cm HPLC column (Spectronex, Basel, Switzerland) connected online to an ion-trap Finnigan DecaXP (ThermoFinnigan, San Jose, CA, USA). A linear gradient from 5 to 50% solvent B (0.1% formic acid and 80% (v/v) acetonitrile in water) in solvent A (0.1% formic acid and 2% acetonitrile in water) was delivered in 60 min with a Rheos 2000 HPLC system (Flux, Basel, Switzerland) at 100 mul/min flow rate. A pre-column flow-splitter reduced the flow to approximately300 nl/min and the peptides were manually loaded with a 10 mul Hamilton syringe on a peptide cap-trap cartridge (Michrom BioResources, Auburn, CA, USA) mounted in the injection loop of the MS. The eluting peptides were ionized by electrospray ionization, detected and the peptide ions were automatically selected and fragmented by collision-induced dissociation (MS/MS) in the ion trap. Individual MS/MS spectra were compared against the known protein sequence using TurboSequest software (36). Phosphorylated peptides were sequenced more than once.
###end p 39
###begin title 40
RESULTS AND DISCUSSION
###end title 40
###begin title 41
hEXO1 is phosphorylated in response to fork arrest
###end title 41
###begin p 42
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 897 905 897 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 980 982 980 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 1198 1200 1198 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 1379 1387 1379 1387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1522 1530 1522 1530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1844 1848 1844 1848 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1981</sub>
###xml 1908 1910 1908 1910 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sub>
###xml 2258 2260 2258 2260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 2336 2338 2336 2338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 2518 2520 2518 2520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 2616 2624 2616 2624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 2796 2804 2796 2804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 3072 3080 3072 3080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 3436 3438 3436 3438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 3529 3531 3529 3531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 3875 3883 3875 3883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 4156 4164 4156 4164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 4196 4205 4196 4205 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1.</label>
###xml 4283 4284 4283 4284 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 4682 4683 4682 4683 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 5265 5266 5263 5264 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 5703 5704 5701 5702 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 6027 6028 6025 6026 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 4205 6300 4205 6298 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="43">ATR-dependent control of hEXO1 stability in response to stalled replication. (<bold>A</bold>) HEK-293, U2OS, HeLa and MEF cells were grown in the presence or the absence of 2 mM HU for 24 h. Whole cell extracts were immunoprecipitated with the rabbit polyclonal antibody F-15 and resolved on a 8% SDS&#8211;PAGE. Human and mouse EXO1 were visualized with the monoclonal antibody Ab-4. MSH6 and IgG(H) were used as controls for the input and the quality of the immunoprecipitation, respectively. (<bold>B</bold>) Upper panels: immunoprecipitation of hEXO1 from HEK-293T cells left untreated (lane 1) or treated for 8 h with either 10 &#956;M KU-55933 (lane 2), 4 mM caffeine (lane 3), 2 mM HU (lane 4), 4 mM caffeine followed by 2 mM HU (lane 5) or 10 &#956;M KU-55933 followed by 2 mM HU (lane 6). hEXO1 was detected as described above. The signal given by IgG(H) was used as control for the quality of the immunoprecipitation. Lower panels: western blot analysis of phosphorylated CHK1 in whole cell extracts was used as read-out for the cellular response to HU. TFIIH was used as loading control. (<bold>C</bold>) HEK-293T cells were stably transfected with EV, ATR or ATM shRNA constructs. hEXO1 was immunoprecipitated from cells left untreated or treated with HU for 16 h. The signal given by IgG(H) was used as control for the quality of the immunoprecipitation. ATR and ATM expression was monitored to assess the extent of downregulation by shRNA. TFIIH served as loading control. The data shown represent one of three independent experiments. (<bold>D</bold>) ATR-Seckel cells at early or late passages were either left untreated or treated with HU for 16 h. hEXO1 was immunoprecipitated as described above. TFIIH and IgG(H) were used as controls for the input and the quality of the immunoprecipitation, respectively. The expression of ATR was examined by western blot analysis. (<bold>E</bold>) AT or AT + ATM fibroblasts were treated in the presence or the absence of HU and the expression of hEXO1 was assessed following immunoprecipitation as described above. TFIIH and IgG(H) were used as controls for input and quality of the immunoprecipitation, respectively.</p>
###xml 4205 6300 4205 6298 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="43">ATR-dependent control of hEXO1 stability in response to stalled replication. (<bold>A</bold>) HEK-293, U2OS, HeLa and MEF cells were grown in the presence or the absence of 2 mM HU for 24 h. Whole cell extracts were immunoprecipitated with the rabbit polyclonal antibody F-15 and resolved on a 8% SDS&#8211;PAGE. Human and mouse EXO1 were visualized with the monoclonal antibody Ab-4. MSH6 and IgG(H) were used as controls for the input and the quality of the immunoprecipitation, respectively. (<bold>B</bold>) Upper panels: immunoprecipitation of hEXO1 from HEK-293T cells left untreated (lane 1) or treated for 8 h with either 10 &#956;M KU-55933 (lane 2), 4 mM caffeine (lane 3), 2 mM HU (lane 4), 4 mM caffeine followed by 2 mM HU (lane 5) or 10 &#956;M KU-55933 followed by 2 mM HU (lane 6). hEXO1 was detected as described above. The signal given by IgG(H) was used as control for the quality of the immunoprecipitation. Lower panels: western blot analysis of phosphorylated CHK1 in whole cell extracts was used as read-out for the cellular response to HU. TFIIH was used as loading control. (<bold>C</bold>) HEK-293T cells were stably transfected with EV, ATR or ATM shRNA constructs. hEXO1 was immunoprecipitated from cells left untreated or treated with HU for 16 h. The signal given by IgG(H) was used as control for the quality of the immunoprecipitation. ATR and ATM expression was monitored to assess the extent of downregulation by shRNA. TFIIH served as loading control. The data shown represent one of three independent experiments. (<bold>D</bold>) ATR-Seckel cells at early or late passages were either left untreated or treated with HU for 16 h. hEXO1 was immunoprecipitated as described above. TFIIH and IgG(H) were used as controls for the input and the quality of the immunoprecipitation, respectively. The expression of ATR was examined by western blot analysis. (<bold>E</bold>) AT or AT + ATM fibroblasts were treated in the presence or the absence of HU and the expression of hEXO1 was assessed following immunoprecipitation as described above. TFIIH and IgG(H) were used as controls for input and quality of the immunoprecipitation, respectively.</p></caption>
###xml 6300 6300 6298 6298 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm1052f1"/>
###xml 4196 6300 4196 6298 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F1" position="float"><label>Figure 1.</label><caption><p textid="43">ATR-dependent control of hEXO1 stability in response to stalled replication. (<bold>A</bold>) HEK-293, U2OS, HeLa and MEF cells were grown in the presence or the absence of 2 mM HU for 24 h. Whole cell extracts were immunoprecipitated with the rabbit polyclonal antibody F-15 and resolved on a 8% SDS&#8211;PAGE. Human and mouse EXO1 were visualized with the monoclonal antibody Ab-4. MSH6 and IgG(H) were used as controls for the input and the quality of the immunoprecipitation, respectively. (<bold>B</bold>) Upper panels: immunoprecipitation of hEXO1 from HEK-293T cells left untreated (lane 1) or treated for 8 h with either 10 &#956;M KU-55933 (lane 2), 4 mM caffeine (lane 3), 2 mM HU (lane 4), 4 mM caffeine followed by 2 mM HU (lane 5) or 10 &#956;M KU-55933 followed by 2 mM HU (lane 6). hEXO1 was detected as described above. The signal given by IgG(H) was used as control for the quality of the immunoprecipitation. Lower panels: western blot analysis of phosphorylated CHK1 in whole cell extracts was used as read-out for the cellular response to HU. TFIIH was used as loading control. (<bold>C</bold>) HEK-293T cells were stably transfected with EV, ATR or ATM shRNA constructs. hEXO1 was immunoprecipitated from cells left untreated or treated with HU for 16 h. The signal given by IgG(H) was used as control for the quality of the immunoprecipitation. ATR and ATM expression was monitored to assess the extent of downregulation by shRNA. TFIIH served as loading control. The data shown represent one of three independent experiments. (<bold>D</bold>) ATR-Seckel cells at early or late passages were either left untreated or treated with HU for 16 h. hEXO1 was immunoprecipitated as described above. TFIIH and IgG(H) were used as controls for the input and the quality of the immunoprecipitation, respectively. The expression of ATR was examined by western blot analysis. (<bold>E</bold>) AT or AT + ATM fibroblasts were treated in the presence or the absence of HU and the expression of hEXO1 was assessed following immunoprecipitation as described above. TFIIH and IgG(H) were used as controls for input and quality of the immunoprecipitation, respectively.</p></caption><graphic xlink:href="gkm1052f1"/></fig>
###xml 4436 4442 <span type="species:ncbi:9986">rabbit</span>
###xml 4499 4504 <span type="species:ncbi:9606">Human</span>
###xml 4509 4514 <span type="species:ncbi:10090">mouse</span>
Using HEK-293T cells as model system, we have previously shown that the hEXO1 protein is phosphorylated and that inhibitors of DNA replication, but not genotoxic agents, increase the extent of hEXO1 phosphorylation. This, in turn, results in ubiquitination of hEXO1, which is followed by rapid degradation of the protein in a proteasome-dependent manner (32). To assess whether this is a peculiarity of HEK-293T cells or a common response to agent that stall replication, we analyzed the parental HEK-293 cells along with HeLa, U2OS, MEF and NIH3T3 cells. In all cases, visualization of hEXO1 required immunoprecipitation, as the amount of hEXO1 protein present in total extracts was below the threshold of detection of western blot analysis. This confirmed that hEXO1 is a rare protein in all cell lines examined. Moreover, in all cases treatment with HU led to decrease of hEXO1 protein amount (Figure 1A and Supplementary Figure 1A), as previously reported for HEK-293T cells (32). In order to identify the DNA structure checkpoint pathway that controls phosphorylation of hEXO1, we employed the non-selective PI3K-like kinase inhibitor caffeine as well as the selective ATM inhibitor KU-55933 (37). Addition of caffeine to HEK-293T cells prior to the treatment with HU abolished activation of the ATR-downstream target CHK1 and led to rescue of HU-induced hEXO1 degradation (Figure 1B, compare lane 4 with lane 5). This, however, was not the case when cells were pre-treated with the selective ATM inhibitor KU-55933 (Figure 1B, compare lane 4 with lane 6). In order to assess whether KU-55933 was functional under our assay conditions, we treated HEK-293T cells with the compound prior to administering ionizing radiation (10 Gy) or HU (2 mM). The data showed that whereas KU-55933 was very effective in inhibiting ATM phosphorylation at S1981 as well phosphorylation of the downstream effector p53 at S15 in response to IR, the inhibitor could not block either of the two events in cells treated with HU (Supplementary Figure 1B). This indicates that the kinase activated in response to HU was ATR. The ATR-dependent phosphorylation of ATM that we observed is in agreement with evidence previously reported in the literature for UV-induced DNA damage (38) and confirms the reported cross-talk between these two PI3K-like kinases (39). To substantiate the finding that ATR controls hEXO1 stability, we examined the effect of down-regulating ATR or ATM by means of RNA interference. The shRNA constructs employed (34) led to a specific, although not compete, reduction of the level of the two PI3K-like kinases (Figure 1C). In this setting, the HU-induced hEXO1 degradation was only rescued upon knocking-down ATR expression. The residual hEXO1 protein upon HU treatment was 35%, 57% or 37% (Figure 1C, lanes 2, 4 and 6, respectively) as compared to the untreated controls. The fact that the rescue of hEXO1 degradation observed in these experiments was partial might depend on the potency of the shRNA to ATR, which appeared to be less effective than the one to ATM (Figure 1C). Quantification of the data indicated that the reduction of protein expression was 75% for ATM and 55% for ATR. In order to get a more definitive answer to the involvement of ATR in the control of hEXO1 stability, we examined the ATR-Seckel cell line. These cells carry a mutated ATR allele that is transcribed in an mRNA undergoing incorrect splicing (40). Nonetheless, ATR-Seckel cells maintain low level of the correctly spliced mRNA for ATR (40) and in the course of culturing, display increasing expression of functional ATR (M. O'Driscoll and P. Jeggo, personal communication). Such model appeared to be ideal to assess the effect of differential level of ATR on hEXO1 stability. In this system, we observed that the expression of hEXO1 was higher in early- than in late-passage cells (Figure 1D, compare lane 1 with lane 3), in a manner that was inversely proportional to the level of expressed ATR. More importantly, treatment of late-passage Seckel cells with HU led to a clear decrease in the amount of hEXO1, an effect that did not occur in early passage cells (Figure 1D, compare lane 4 with lane 2). Figure 1.ATR-dependent control of hEXO1 stability in response to stalled replication. (A) HEK-293, U2OS, HeLa and MEF cells were grown in the presence or the absence of 2 mM HU for 24 h. Whole cell extracts were immunoprecipitated with the rabbit polyclonal antibody F-15 and resolved on a 8% SDS-PAGE. Human and mouse EXO1 were visualized with the monoclonal antibody Ab-4. MSH6 and IgG(H) were used as controls for the input and the quality of the immunoprecipitation, respectively. (B) Upper panels: immunoprecipitation of hEXO1 from HEK-293T cells left untreated (lane 1) or treated for 8 h with either 10 muM KU-55933 (lane 2), 4 mM caffeine (lane 3), 2 mM HU (lane 4), 4 mM caffeine followed by 2 mM HU (lane 5) or 10 muM KU-55933 followed by 2 mM HU (lane 6). hEXO1 was detected as described above. The signal given by IgG(H) was used as control for the quality of the immunoprecipitation. Lower panels: western blot analysis of phosphorylated CHK1 in whole cell extracts was used as read-out for the cellular response to HU. TFIIH was used as loading control. (C) HEK-293T cells were stably transfected with EV, ATR or ATM shRNA constructs. hEXO1 was immunoprecipitated from cells left untreated or treated with HU for 16 h. The signal given by IgG(H) was used as control for the quality of the immunoprecipitation. ATR and ATM expression was monitored to assess the extent of downregulation by shRNA. TFIIH served as loading control. The data shown represent one of three independent experiments. (D) ATR-Seckel cells at early or late passages were either left untreated or treated with HU for 16 h. hEXO1 was immunoprecipitated as described above. TFIIH and IgG(H) were used as controls for the input and the quality of the immunoprecipitation, respectively. The expression of ATR was examined by western blot analysis. (E) AT or AT + ATM fibroblasts were treated in the presence or the absence of HU and the expression of hEXO1 was assessed following immunoprecipitation as described above. TFIIH and IgG(H) were used as controls for input and quality of the immunoprecipitation, respectively.
###end p 42
###begin p 43
###xml 78 79 78 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 477 478 477 478 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1060 1061 1058 1059 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1498 1499 1496 1497 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1822 1823 1820 1821 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 231 237 <span type="species:ncbi:9986">rabbit</span>
###xml 294 299 <span type="species:ncbi:9606">Human</span>
###xml 304 309 <span type="species:ncbi:10090">mouse</span>
ATR-dependent control of hEXO1 stability in response to stalled replication. (A) HEK-293, U2OS, HeLa and MEF cells were grown in the presence or the absence of 2 mM HU for 24 h. Whole cell extracts were immunoprecipitated with the rabbit polyclonal antibody F-15 and resolved on a 8% SDS-PAGE. Human and mouse EXO1 were visualized with the monoclonal antibody Ab-4. MSH6 and IgG(H) were used as controls for the input and the quality of the immunoprecipitation, respectively. (B) Upper panels: immunoprecipitation of hEXO1 from HEK-293T cells left untreated (lane 1) or treated for 8 h with either 10 muM KU-55933 (lane 2), 4 mM caffeine (lane 3), 2 mM HU (lane 4), 4 mM caffeine followed by 2 mM HU (lane 5) or 10 muM KU-55933 followed by 2 mM HU (lane 6). hEXO1 was detected as described above. The signal given by IgG(H) was used as control for the quality of the immunoprecipitation. Lower panels: western blot analysis of phosphorylated CHK1 in whole cell extracts was used as read-out for the cellular response to HU. TFIIH was used as loading control. (C) HEK-293T cells were stably transfected with EV, ATR or ATM shRNA constructs. hEXO1 was immunoprecipitated from cells left untreated or treated with HU for 16 h. The signal given by IgG(H) was used as control for the quality of the immunoprecipitation. ATR and ATM expression was monitored to assess the extent of downregulation by shRNA. TFIIH served as loading control. The data shown represent one of three independent experiments. (D) ATR-Seckel cells at early or late passages were either left untreated or treated with HU for 16 h. hEXO1 was immunoprecipitated as described above. TFIIH and IgG(H) were used as controls for the input and the quality of the immunoprecipitation, respectively. The expression of ATR was examined by western blot analysis. (E) AT or AT + ATM fibroblasts were treated in the presence or the absence of HU and the expression of hEXO1 was assessed following immunoprecipitation as described above. TFIIH and IgG(H) were used as controls for input and quality of the immunoprecipitation, respectively.
###end p 43
###begin p 44
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 274 282 274 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 131 138 <span type="species:ncbi:9606">patient</span>
To finally confirm the lack of involvement of ATM in signaling to hEXO1, we examined the response of fibroblast derived from an AT-patient (33). Both in ATM-deficient and -proficient fibroblasts, hEXO1 displayed a similar pattern of degradation in response to HU treatment (Figure 1E), thus ruling out a role for ATM in this process. Taken together, these data show that the stalled-fork signal was relayed to hEXO1 through an ATR-dependent pathway.
###end p 44
###begin title 45
Identification of the sites of phosphorylation in hEXO1
###end title 45
###begin p 46
###xml 278 286 278 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 636 643 636 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 645 653 645 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 732 735 732 735 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">454</sub>
###xml 738 741 738 741 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">621</sub>
###xml 747 750 747 750 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 1074 1077 1074 1077 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">376</sub>
###xml 1080 1083 1080 1083 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">598</sub>
###xml 1086 1089 1086 1089 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">623</sub>
###xml 1095 1098 1095 1098 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">639</sub>
###xml 1183 1186 1183 1186 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">581</sub>
###xml 1192 1195 1192 1195 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">660</sub>
###xml 1232 1235 1232 1235 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;2</sub>
###xml 1253 1256 1253 1256 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">422</sub>
###xml 1262 1265 1262 1265 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">746</sub>
###xml 1337 1338 1335 1336 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1481 1484 1477 1480 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">598</sub>
###xml 1584 1586 1580 1582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 1683 1686 1679 1682 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 1728 1737 1724 1733 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2.</label>
###xml 1795 1796 1791 1792 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 2395 2396 2391 2392 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1737 2613 1733 2609 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="47">Identification of the sites of phosphorylation in hEXO1. (<bold>A</bold>) HEK-293 cells were transfected with EV (lane 3) or an expression vector encoding Omni-hEXO1 (lanes 4&#8211;7). Cells were left untreated (lanes 4 and 5) or treated with 2 mM HU for 24 h (lanes 6 and 7). hEXO1 was immmunoprecipitated with the Omni-probe antibody. Samples were subjected to 8% SDS&#8211;PAGE electrophoresis and the gel was stained with Coomassie Brilliant Blue. Molecular weight protein markers (lane 1) and 500 ng BSA (lane 2) were loaded to estimate the amount of immunoprecipitated hEXO1. The protein bands corresponding to hEXO1 were excised from the gel and underwent LC-MS/MS analysis. (<bold>B</bold>) Schematic representation of hEXO1 and localization of the sites of phosphorylation identified by LC-MS/MS. N-terminal (N) and internal (I) catalytic domains are indicated. Dots, basal sites; stars, HU-induced sites.</p>
###xml 1737 2613 1733 2609 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="47">Identification of the sites of phosphorylation in hEXO1. (<bold>A</bold>) HEK-293 cells were transfected with EV (lane 3) or an expression vector encoding Omni-hEXO1 (lanes 4&#8211;7). Cells were left untreated (lanes 4 and 5) or treated with 2 mM HU for 24 h (lanes 6 and 7). hEXO1 was immmunoprecipitated with the Omni-probe antibody. Samples were subjected to 8% SDS&#8211;PAGE electrophoresis and the gel was stained with Coomassie Brilliant Blue. Molecular weight protein markers (lane 1) and 500 ng BSA (lane 2) were loaded to estimate the amount of immunoprecipitated hEXO1. The protein bands corresponding to hEXO1 were excised from the gel and underwent LC-MS/MS analysis. (<bold>B</bold>) Schematic representation of hEXO1 and localization of the sites of phosphorylation identified by LC-MS/MS. N-terminal (N) and internal (I) catalytic domains are indicated. Dots, basal sites; stars, HU-induced sites.</p></caption>
###xml 2613 2613 2609 2609 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm1052f2"/>
###xml 1728 2613 1724 2609 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F2" position="float"><label>Figure 2.</label><caption><p textid="47">Identification of the sites of phosphorylation in hEXO1. (<bold>A</bold>) HEK-293 cells were transfected with EV (lane 3) or an expression vector encoding Omni-hEXO1 (lanes 4&#8211;7). Cells were left untreated (lanes 4 and 5) or treated with 2 mM HU for 24 h (lanes 6 and 7). hEXO1 was immmunoprecipitated with the Omni-probe antibody. Samples were subjected to 8% SDS&#8211;PAGE electrophoresis and the gel was stained with Coomassie Brilliant Blue. Molecular weight protein markers (lane 1) and 500 ng BSA (lane 2) were loaded to estimate the amount of immunoprecipitated hEXO1. The protein bands corresponding to hEXO1 were excised from the gel and underwent LC-MS/MS analysis. (<bold>B</bold>) Schematic representation of hEXO1 and localization of the sites of phosphorylation identified by LC-MS/MS. N-terminal (N) and internal (I) catalytic domains are indicated. Dots, basal sites; stars, HU-induced sites.</p></caption><graphic xlink:href="gkm1052f2"/></fig>
###xml 2613 2621 2609 2617 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1.</label>
###xml 2621 2748 2617 2744 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="48">Sites of phosphorylation that were identified in hEXO1 phosphopeptides present among the peptides detected in LC&#8211;MS/MS analysis</p>
###xml 2621 2748 2617 2744 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="48">Sites of phosphorylation that were identified in hEXO1 phosphopeptides present among the peptides detected in LC&#8211;MS/MS analysis</p></caption>
###xml 2748 2762 2744 2758 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Phosphopeptide</th>
###xml 2762 2774 2758 2770 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Phospho-site</th>
###xml 2774 2783 2770 2779 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Treatment</th>
###xml 2748 2783 2744 2779 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><th rowspan="1" colspan="1">Phosphopeptide</th><th rowspan="1" colspan="1">Phospho-site</th><th rowspan="1" colspan="1">Treatment</th></tr>
###xml 2748 2783 2744 2779 <thead xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><th rowspan="1" colspan="1">Phosphopeptide</th><th rowspan="1" colspan="1">Phospho-site</th><th rowspan="1" colspan="1">Treatment</th></tr></thead>
###xml 2787 2789 2783 2785 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pS</bold>
###xml 2783 2793 2779 2789 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">HRNY<bold>pS</bold>PRPE</td>
###xml 2796 2799 2792 2795 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">376</sub>
###xml 2793 2799 2789 2795 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Ser<sub>376</sub></td>
###xml 2799 2803 2795 2799 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">None</td>
###xml 2783 2803 2779 2799 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">HRNY<bold>pS</bold>PRPE</td><td rowspan="1" colspan="1">Ser<sub>376</sub></td><td rowspan="1" colspan="1">None</td></tr>
###xml 2807 2809 2803 2805 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pS</bold>
###xml 2803 2813 2799 2809 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">KRPR<bold>pS</bold>AELS</td>
###xml 2816 2819 2812 2815 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">422</sub>
###xml 2813 2819 2809 2815 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Ser<sub>422</sub></td>
###xml 2819 2823 2815 2819 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">None</td>
###xml 2803 2823 2799 2819 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">KRPR<bold>pS</bold>AELS</td><td rowspan="1" colspan="1">Ser<sub>422</sub></td><td rowspan="1" colspan="1">None</td></tr>
###xml 2827 2829 2823 2825 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pT</bold>
###xml 2823 2833 2819 2829 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">ATVF<bold>pT</bold>DEES</td>
###xml 2836 2839 2832 2835 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">581</sub>
###xml 2833 2839 2829 2835 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Thr<sub>581</sub></td>
###xml 2839 2843 2835 2839 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">None</td>
###xml 2823 2843 2819 2839 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">ATVF<bold>pT</bold>DEES</td><td rowspan="1" colspan="1">Thr<sub>581</sub></td><td rowspan="1" colspan="1">None</td></tr>
###xml 2847 2849 2843 2845 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pS</bold>
###xml 2843 2853 2839 2849 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">TRTI<bold>pS</bold>PPTL</td>
###xml 2856 2859 2852 2855 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">598</sub>
###xml 2853 2859 2849 2855 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Ser<sub>598</sub></td>
###xml 2859 2863 2855 2859 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">None</td>
###xml 2843 2863 2839 2859 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">TRTI<bold>pS</bold>PPTL</td><td rowspan="1" colspan="1">Ser<sub>598</sub></td><td rowspan="1" colspan="1">None</td></tr>
###xml 2867 2869 2863 2865 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pS</bold>
###xml 2863 2873 2859 2869 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">SRTP<bold>pS</bold>PSPS</td>
###xml 2876 2879 2872 2875 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">623</sub>
###xml 2873 2879 2869 2875 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Ser<sub>623</sub></td>
###xml 2879 2883 2875 2879 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">None</td>
###xml 2863 2883 2859 2879 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">SRTP<bold>pS</bold>PSPS</td><td rowspan="1" colspan="1">Ser<sub>623</sub></td><td rowspan="1" colspan="1">None</td></tr>
###xml 2887 2889 2883 2885 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pS</bold>
###xml 2883 2893 2879 2889 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">RKSD<bold>pS</bold>PTSL</td>
###xml 2896 2899 2892 2895 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">639</sub>
###xml 2893 2899 2889 2895 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Ser<sub>639</sub></td>
###xml 2899 2903 2895 2899 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">None</td>
###xml 2883 2903 2879 2899 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">RKSD<bold>pS</bold>PTSL</td><td rowspan="1" colspan="1">Ser<sub>639</sub></td><td rowspan="1" colspan="1">None</td></tr>
###xml 2907 2909 2903 2905 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pS</bold>
###xml 2903 2913 2899 2909 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">SEES<bold>pS</bold>DDES</td>
###xml 2916 2919 2912 2915 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">660</sub>
###xml 2913 2919 2909 2915 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Ser<sub>660</sub></td>
###xml 2919 2923 2915 2919 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">None</td>
###xml 2903 2923 2899 2919 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">SEES<bold>pS</bold>DDES</td><td rowspan="1" colspan="1">Ser<sub>660</sub></td><td rowspan="1" colspan="1">None</td></tr>
###xml 2927 2929 2923 2925 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pS</bold>
###xml 2923 2933 2919 2929 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GACS<bold>pS</bold>QSQE</td>
###xml 2936 2939 2932 2935 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">674</sub>
###xml 2933 2939 2929 2935 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Ser<sub>674</sub></td>
###xml 2939 2943 2935 2939 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">None</td>
###xml 2923 2943 2919 2939 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">GACS<bold>pS</bold>QSQE</td><td rowspan="1" colspan="1">Ser<sub>674</sub></td><td rowspan="1" colspan="1">None</td></tr>
###xml 2947 2949 2943 2945 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pS</bold>
###xml 2943 2953 2939 2949 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">YKSS<bold>pS</bold>ADSL</td>
###xml 2956 2959 2952 2955 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">746</sub>
###xml 2953 2959 2949 2955 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Ser<sub>746</sub></td>
###xml 2959 2963 2955 2959 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">None</td>
###xml 2943 2963 2939 2959 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">YKSS<bold>pS</bold>ADSL</td><td rowspan="1" colspan="1">Ser<sub>746</sub></td><td rowspan="1" colspan="1">None</td></tr>
###xml 2967 2969 2963 2965 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pS</bold>
###xml 2963 2973 2959 2969 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NKSL<bold>pS</bold>FSEV</td>
###xml 2976 2979 2972 2975 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">454</sub>
###xml 2973 2979 2969 2975 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Ser<sub>454</sub></td>
###xml 2979 2981 2975 2977 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">HU</td>
###xml 2963 2981 2959 2977 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">NKSL<bold>pS</bold>FSEV</td><td rowspan="1" colspan="1">Ser<sub>454</sub></td><td rowspan="1" colspan="1">HU</td></tr>
###xml 2985 2987 2981 2983 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pT</bold>
###xml 2981 2991 2977 2987 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">DSFR<bold>pT</bold>PSPS</td>
###xml 2994 2997 2990 2993 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">621</sub>
###xml 2991 2997 2987 2993 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Thr<sub>621</sub></td>
###xml 2997 2999 2993 2995 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">HU</td>
###xml 2981 2999 2977 2995 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">DSFR<bold>pT</bold>PSPS</td><td rowspan="1" colspan="1">Thr<sub>621</sub></td><td rowspan="1" colspan="1">HU</td></tr>
###xml 3003 3005 2999 3001 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pS</bold>
###xml 2999 3009 2995 3005 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">KLLD<bold>pS</bold>QSDQ</td>
###xml 3012 3015 3008 3011 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 3009 3015 3005 3011 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Ser<sub>714</sub></td>
###xml 3015 3017 3011 3013 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">HU</td>
###xml 2999 3017 2995 3013 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">KLLD<bold>pS</bold>QSDQ</td><td rowspan="1" colspan="1">Ser<sub>714</sub></td><td rowspan="1" colspan="1">HU</td></tr>
###xml 2783 3017 2779 3013 <tbody xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><td rowspan="1" colspan="1">HRNY<bold>pS</bold>PRPE</td><td rowspan="1" colspan="1">Ser<sub>376</sub></td><td rowspan="1" colspan="1">None</td></tr><tr><td rowspan="1" colspan="1">KRPR<bold>pS</bold>AELS</td><td rowspan="1" colspan="1">Ser<sub>422</sub></td><td rowspan="1" colspan="1">None</td></tr><tr><td rowspan="1" colspan="1">ATVF<bold>pT</bold>DEES</td><td rowspan="1" colspan="1">Thr<sub>581</sub></td><td rowspan="1" colspan="1">None</td></tr><tr><td rowspan="1" colspan="1">TRTI<bold>pS</bold>PPTL</td><td rowspan="1" colspan="1">Ser<sub>598</sub></td><td rowspan="1" colspan="1">None</td></tr><tr><td rowspan="1" colspan="1">SRTP<bold>pS</bold>PSPS</td><td rowspan="1" colspan="1">Ser<sub>623</sub></td><td rowspan="1" colspan="1">None</td></tr><tr><td rowspan="1" colspan="1">RKSD<bold>pS</bold>PTSL</td><td rowspan="1" colspan="1">Ser<sub>639</sub></td><td rowspan="1" colspan="1">None</td></tr><tr><td rowspan="1" colspan="1">SEES<bold>pS</bold>DDES</td><td rowspan="1" colspan="1">Ser<sub>660</sub></td><td rowspan="1" colspan="1">None</td></tr><tr><td rowspan="1" colspan="1">GACS<bold>pS</bold>QSQE</td><td rowspan="1" colspan="1">Ser<sub>674</sub></td><td rowspan="1" colspan="1">None</td></tr><tr><td rowspan="1" colspan="1">YKSS<bold>pS</bold>ADSL</td><td rowspan="1" colspan="1">Ser<sub>746</sub></td><td rowspan="1" colspan="1">None</td></tr><tr><td rowspan="1" colspan="1">NKSL<bold>pS</bold>FSEV</td><td rowspan="1" colspan="1">Ser<sub>454</sub></td><td rowspan="1" colspan="1">HU</td></tr><tr><td rowspan="1" colspan="1">DSFR<bold>pT</bold>PSPS</td><td rowspan="1" colspan="1">Thr<sub>621</sub></td><td rowspan="1" colspan="1">HU</td></tr><tr><td rowspan="1" colspan="1">KLLD<bold>pS</bold>QSDQ</td><td rowspan="1" colspan="1">Ser<sub>714</sub></td><td rowspan="1" colspan="1">HU</td></tr></tbody>
###xml 2748 3017 2744 3013 <table xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Phosphopeptide</th><th rowspan="1" colspan="1">Phospho-site</th><th rowspan="1" colspan="1">Treatment</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">HRNY<bold>pS</bold>PRPE</td><td rowspan="1" colspan="1">Ser<sub>376</sub></td><td rowspan="1" colspan="1">None</td></tr><tr><td rowspan="1" colspan="1">KRPR<bold>pS</bold>AELS</td><td rowspan="1" colspan="1">Ser<sub>422</sub></td><td rowspan="1" colspan="1">None</td></tr><tr><td rowspan="1" colspan="1">ATVF<bold>pT</bold>DEES</td><td rowspan="1" colspan="1">Thr<sub>581</sub></td><td rowspan="1" colspan="1">None</td></tr><tr><td rowspan="1" colspan="1">TRTI<bold>pS</bold>PPTL</td><td rowspan="1" colspan="1">Ser<sub>598</sub></td><td rowspan="1" colspan="1">None</td></tr><tr><td rowspan="1" colspan="1">SRTP<bold>pS</bold>PSPS</td><td rowspan="1" colspan="1">Ser<sub>623</sub></td><td rowspan="1" colspan="1">None</td></tr><tr><td rowspan="1" colspan="1">RKSD<bold>pS</bold>PTSL</td><td rowspan="1" colspan="1">Ser<sub>639</sub></td><td rowspan="1" colspan="1">None</td></tr><tr><td rowspan="1" colspan="1">SEES<bold>pS</bold>DDES</td><td rowspan="1" colspan="1">Ser<sub>660</sub></td><td rowspan="1" colspan="1">None</td></tr><tr><td rowspan="1" colspan="1">GACS<bold>pS</bold>QSQE</td><td rowspan="1" colspan="1">Ser<sub>674</sub></td><td rowspan="1" colspan="1">None</td></tr><tr><td rowspan="1" colspan="1">YKSS<bold>pS</bold>ADSL</td><td rowspan="1" colspan="1">Ser<sub>746</sub></td><td rowspan="1" colspan="1">None</td></tr><tr><td rowspan="1" colspan="1">NKSL<bold>pS</bold>FSEV</td><td rowspan="1" colspan="1">Ser<sub>454</sub></td><td rowspan="1" colspan="1">HU</td></tr><tr><td rowspan="1" colspan="1">DSFR<bold>pT</bold>PSPS</td><td rowspan="1" colspan="1">Thr<sub>621</sub></td><td rowspan="1" colspan="1">HU</td></tr><tr><td rowspan="1" colspan="1">KLLD<bold>pS</bold>QSDQ</td><td rowspan="1" colspan="1">Ser<sub>714</sub></td><td rowspan="1" colspan="1">HU</td></tr></tbody></table>
###xml 2613 3017 2609 3013 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T1" position="float"><label>Table 1.</label><caption><p textid="48">Sites of phosphorylation that were identified in hEXO1 phosphopeptides present among the peptides detected in LC&#8211;MS/MS analysis</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Phosphopeptide</th><th rowspan="1" colspan="1">Phospho-site</th><th rowspan="1" colspan="1">Treatment</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">HRNY<bold>pS</bold>PRPE</td><td rowspan="1" colspan="1">Ser<sub>376</sub></td><td rowspan="1" colspan="1">None</td></tr><tr><td rowspan="1" colspan="1">KRPR<bold>pS</bold>AELS</td><td rowspan="1" colspan="1">Ser<sub>422</sub></td><td rowspan="1" colspan="1">None</td></tr><tr><td rowspan="1" colspan="1">ATVF<bold>pT</bold>DEES</td><td rowspan="1" colspan="1">Thr<sub>581</sub></td><td rowspan="1" colspan="1">None</td></tr><tr><td rowspan="1" colspan="1">TRTI<bold>pS</bold>PPTL</td><td rowspan="1" colspan="1">Ser<sub>598</sub></td><td rowspan="1" colspan="1">None</td></tr><tr><td rowspan="1" colspan="1">SRTP<bold>pS</bold>PSPS</td><td rowspan="1" colspan="1">Ser<sub>623</sub></td><td rowspan="1" colspan="1">None</td></tr><tr><td rowspan="1" colspan="1">RKSD<bold>pS</bold>PTSL</td><td rowspan="1" colspan="1">Ser<sub>639</sub></td><td rowspan="1" colspan="1">None</td></tr><tr><td rowspan="1" colspan="1">SEES<bold>pS</bold>DDES</td><td rowspan="1" colspan="1">Ser<sub>660</sub></td><td rowspan="1" colspan="1">None</td></tr><tr><td rowspan="1" colspan="1">GACS<bold>pS</bold>QSQE</td><td rowspan="1" colspan="1">Ser<sub>674</sub></td><td rowspan="1" colspan="1">None</td></tr><tr><td rowspan="1" colspan="1">YKSS<bold>pS</bold>ADSL</td><td rowspan="1" colspan="1">Ser<sub>746</sub></td><td rowspan="1" colspan="1">None</td></tr><tr><td rowspan="1" colspan="1">NKSL<bold>pS</bold>FSEV</td><td rowspan="1" colspan="1">Ser<sub>454</sub></td><td rowspan="1" colspan="1">HU</td></tr><tr><td rowspan="1" colspan="1">DSFR<bold>pT</bold>PSPS</td><td rowspan="1" colspan="1">Thr<sub>621</sub></td><td rowspan="1" colspan="1">HU</td></tr><tr><td rowspan="1" colspan="1">KLLD<bold>pS</bold>QSDQ</td><td rowspan="1" colspan="1">Ser<sub>714</sub></td><td rowspan="1" colspan="1">HU</td></tr></tbody></table></table-wrap>
Having established that hEXO1 was phosphorylated in an ATR-dependent manner in response to stalled forks, we set out to identify the sites of phosphorylation. To this end, we ectopically expressed an Omni-tagged form of hEXO1 in HEK-293 cells. Large-scale immunoprecipitations (Figure 2A) allowed us to obtain sufficient amount of hEXO1 protein to perform LC-MS/MS analysis. In typical experiments, we were able to cover >85% of hEXO1 sequence (Supplementary Figure 2). The results show that hEXO1 was phosphorylated at nine residues (8 Ser, 1 Thr) under basal conditions and at three additional sites (2 Ser, 1 Thr) upon HU treatment (Table 1, Figure 2B and Supplementary Figure 2). The three HU-induced sites of phosphorylation (S454, T621 and S714) conformed to the requirement for recognition by CHK1/CHK2, MAPK/SAPK and ATM/ATR, respectively. These findings point to the involvement of classic DNA damage signaling pathways as well as stress-activated kinase cascades in hEXO1 phosphorylation in response to HU. Among the nine basal sites of phosphorylation, residues S376, S598, S623 and S639 conformed to the recognition by proline-directed kinases (S/T-P), whereas residues T581 and S660 resembled typical CK2 targets (S/T-X1-2-D/E). The sites S422 and S746 fulfilled the requirement for phosphorylation by CHK1/CHK2 (Phi-X-K/R-X2-S/T, where Phi is any hydrophobic amino acid), or, as second choice, for CK2. Among the basal sites of phosphorylation that we identified is S598, a site that was previously described in a large-scale study on HeLa cell nuclear phosphoproteome (41). A representative MS-chromatogram for the identification of phosphorylation at the HU-induced S714 site is shown in Supplementary Figure 3. Figure 2.Identification of the sites of phosphorylation in hEXO1. (A) HEK-293 cells were transfected with EV (lane 3) or an expression vector encoding Omni-hEXO1 (lanes 4-7). Cells were left untreated (lanes 4 and 5) or treated with 2 mM HU for 24 h (lanes 6 and 7). hEXO1 was immmunoprecipitated with the Omni-probe antibody. Samples were subjected to 8% SDS-PAGE electrophoresis and the gel was stained with Coomassie Brilliant Blue. Molecular weight protein markers (lane 1) and 500 ng BSA (lane 2) were loaded to estimate the amount of immunoprecipitated hEXO1. The protein bands corresponding to hEXO1 were excised from the gel and underwent LC-MS/MS analysis. (B) Schematic representation of hEXO1 and localization of the sites of phosphorylation identified by LC-MS/MS. N-terminal (N) and internal (I) catalytic domains are indicated. Dots, basal sites; stars, HU-induced sites.Table 1.Sites of phosphorylation that were identified in hEXO1 phosphopeptides present among the peptides detected in LC-MS/MS analysisPhosphopeptidePhospho-siteTreatmentHRNYpSPRPESer376NoneKRPRpSAELSSer422NoneATVFpTDEESThr581NoneTRTIpSPPTLSer598NoneSRTPpSPSPSSer623NoneRKSDpSPTSLSer639NoneSEESpSDDESSer660NoneGACSpSQSQESer674NoneYKSSpSADSLSer746NoneNKSLpSFSEVSer454HUDSFRpTPSPSThr621HUKLLDpSQSDQSer714HU
###end p 46
###begin p 47
###xml 58 59 58 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 658 659 658 659 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
Identification of the sites of phosphorylation in hEXO1. (A) HEK-293 cells were transfected with EV (lane 3) or an expression vector encoding Omni-hEXO1 (lanes 4-7). Cells were left untreated (lanes 4 and 5) or treated with 2 mM HU for 24 h (lanes 6 and 7). hEXO1 was immmunoprecipitated with the Omni-probe antibody. Samples were subjected to 8% SDS-PAGE electrophoresis and the gel was stained with Coomassie Brilliant Blue. Molecular weight protein markers (lane 1) and 500 ng BSA (lane 2) were loaded to estimate the amount of immunoprecipitated hEXO1. The protein bands corresponding to hEXO1 were excised from the gel and underwent LC-MS/MS analysis. (B) Schematic representation of hEXO1 and localization of the sites of phosphorylation identified by LC-MS/MS. N-terminal (N) and internal (I) catalytic domains are indicated. Dots, basal sites; stars, HU-induced sites.
###end p 47
###begin p 48
Sites of phosphorylation that were identified in hEXO1 phosphopeptides present among the peptides detected in LC-MS/MS analysis
###end p 48
###begin title 49
###xml 22 25 22 25 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
Characterization of pS714 antibody
###end title 49
###begin p 50
###xml 130 133 130 133 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 380 382 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 622 625 622 625 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 712 720 712 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 804 812 804 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 852 861 852 861 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3.</label>
###xml 893 896 893 896 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 908 909 908 909 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1178 1181 1178 1181 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 1359 1360 1359 1360 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1522 1525 1522 1525 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 1653 1656 1653 1656 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 1659 1660 1659 1660 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1737 1740 1737 1740 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 1885 1886 1885 1886 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 861 2411 861 2411 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="51">Characterization of the hEXO1-pS<sub>714</sub> antibody. (<bold>A</bold>) HeLa cells were transfected with EV (lane 1) or Omni-hEXO1 expression vector (lanes 2 and 3). Cells were left untreated or treated with HU for 24 h. Whole cell extracts were subjected to 8% SDS&#8211;PAGE electrophoresis, followed by western blot analysis using antibody pS<sub>714</sub> to detect phosphorylated hEXO1 (upper panel) or mouse monoclonal antibody Ab-4 to visualize the entire pool of hEXO1 (middle panel). TFIIH served as control for equal loading. (<bold>B</bold>) HEK-293T cells were transfected with EV (lane 1), expression vector for wild-type Omni-hEXO1 (lanes 2 and 3) or for the non-phosphorylatable mutant Omni-hEXO1-A<sub>714</sub> (lane 4). Cells were treated with HU as indicated. Western blot analysis of total cell extracts was performed using antibody pS<sub>714</sub>. (<bold>C</bold>) Immunoprecipitation of endogenous hEXO1 from HEK-293T cells using either pS<sub>714</sub> antibody (upper panel) or rabbit polyclonal antibody F-15 (lower panel) followed by western blot analysis with mouse monoclonal antibody Ab-4. (<bold>D</bold>) HEK-293T cells were transfected with an expression vector for wild-type Omni-hEXO1 (lanes 1&#8211;3). Cells were left untreated or treated with IR (10 Gy) or HU (2 mM), as indicated, and hEXO1 was immunoprecipitated using rabbit polyclonal antibody F-15 (upper panels). The signal given by IgG(H) was used as control for the quality of the immunoprecipitation. The phosphorylation status of hEXO1 and CHK2 was monitored by western blot analysis using phospho-specific antibodies (lower panels). TFIIH was used as loading control.</p>
###xml 861 2411 861 2411 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="51">Characterization of the hEXO1-pS<sub>714</sub> antibody. (<bold>A</bold>) HeLa cells were transfected with EV (lane 1) or Omni-hEXO1 expression vector (lanes 2 and 3). Cells were left untreated or treated with HU for 24 h. Whole cell extracts were subjected to 8% SDS&#8211;PAGE electrophoresis, followed by western blot analysis using antibody pS<sub>714</sub> to detect phosphorylated hEXO1 (upper panel) or mouse monoclonal antibody Ab-4 to visualize the entire pool of hEXO1 (middle panel). TFIIH served as control for equal loading. (<bold>B</bold>) HEK-293T cells were transfected with EV (lane 1), expression vector for wild-type Omni-hEXO1 (lanes 2 and 3) or for the non-phosphorylatable mutant Omni-hEXO1-A<sub>714</sub> (lane 4). Cells were treated with HU as indicated. Western blot analysis of total cell extracts was performed using antibody pS<sub>714</sub>. (<bold>C</bold>) Immunoprecipitation of endogenous hEXO1 from HEK-293T cells using either pS<sub>714</sub> antibody (upper panel) or rabbit polyclonal antibody F-15 (lower panel) followed by western blot analysis with mouse monoclonal antibody Ab-4. (<bold>D</bold>) HEK-293T cells were transfected with an expression vector for wild-type Omni-hEXO1 (lanes 1&#8211;3). Cells were left untreated or treated with IR (10 Gy) or HU (2 mM), as indicated, and hEXO1 was immunoprecipitated using rabbit polyclonal antibody F-15 (upper panels). The signal given by IgG(H) was used as control for the quality of the immunoprecipitation. The phosphorylation status of hEXO1 and CHK2 was monitored by western blot analysis using phospho-specific antibodies (lower panels). TFIIH was used as loading control.</p></caption>
###xml 2411 2411 2411 2411 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm1052f3"/>
###xml 852 2411 852 2411 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F3" position="float"><label>Figure 3.</label><caption><p textid="51">Characterization of the hEXO1-pS<sub>714</sub> antibody. (<bold>A</bold>) HeLa cells were transfected with EV (lane 1) or Omni-hEXO1 expression vector (lanes 2 and 3). Cells were left untreated or treated with HU for 24 h. Whole cell extracts were subjected to 8% SDS&#8211;PAGE electrophoresis, followed by western blot analysis using antibody pS<sub>714</sub> to detect phosphorylated hEXO1 (upper panel) or mouse monoclonal antibody Ab-4 to visualize the entire pool of hEXO1 (middle panel). TFIIH served as control for equal loading. (<bold>B</bold>) HEK-293T cells were transfected with EV (lane 1), expression vector for wild-type Omni-hEXO1 (lanes 2 and 3) or for the non-phosphorylatable mutant Omni-hEXO1-A<sub>714</sub> (lane 4). Cells were treated with HU as indicated. Western blot analysis of total cell extracts was performed using antibody pS<sub>714</sub>. (<bold>C</bold>) Immunoprecipitation of endogenous hEXO1 from HEK-293T cells using either pS<sub>714</sub> antibody (upper panel) or rabbit polyclonal antibody F-15 (lower panel) followed by western blot analysis with mouse monoclonal antibody Ab-4. (<bold>D</bold>) HEK-293T cells were transfected with an expression vector for wild-type Omni-hEXO1 (lanes 1&#8211;3). Cells were left untreated or treated with IR (10 Gy) or HU (2 mM), as indicated, and hEXO1 was immunoprecipitated using rabbit polyclonal antibody F-15 (upper panels). The signal given by IgG(H) was used as control for the quality of the immunoprecipitation. The phosphorylation status of hEXO1 and CHK2 was monitored by western blot analysis using phospho-specific antibodies (lower panels). TFIIH was used as loading control.</p></caption><graphic xlink:href="gkm1052f3"/></fig>
###xml 98 104 <span type="species:ncbi:9986">rabbit</span>
###xml 1230 1235 <span type="species:ncbi:10090">mouse</span>
###xml 1767 1773 <span type="species:ncbi:9986">rabbit</span>
###xml 1852 1857 <span type="species:ncbi:10090">mouse</span>
###xml 2104 2110 <span type="species:ncbi:9986">rabbit</span>
In order to monitor hEXO1 phosphorylation in response to inhibition of DNA synthesis, we raised a rabbit polyclonal antibody to pS714. This site is particularly interesting because it fulfills the requirements for recognition and phosphorylation by ATM/ATR protein kinases and because its phosphorylation has been independently confirmed by large-scale mass spectrometry studies (42) in the course of our work. To assess its specificity, the antibody was tested on total cell extracts derived from HeLa cells that ectopically expressed hEXO1 and were either left untreated or treated with HU. The data indicate that the pS714 antibody selectively detected phosphorylated hEXO1 from extracts of HU-treated cells (Figure 3A, upper panel, lane 3), despite the reduction of total hEXO1 amount induced by HU (Figure 3A, middle panel, lane 3 versus lane 2). Figure 3.Characterization of the hEXO1-pS714 antibody. (A) HeLa cells were transfected with EV (lane 1) or Omni-hEXO1 expression vector (lanes 2 and 3). Cells were left untreated or treated with HU for 24 h. Whole cell extracts were subjected to 8% SDS-PAGE electrophoresis, followed by western blot analysis using antibody pS714 to detect phosphorylated hEXO1 (upper panel) or mouse monoclonal antibody Ab-4 to visualize the entire pool of hEXO1 (middle panel). TFIIH served as control for equal loading. (B) HEK-293T cells were transfected with EV (lane 1), expression vector for wild-type Omni-hEXO1 (lanes 2 and 3) or for the non-phosphorylatable mutant Omni-hEXO1-A714 (lane 4). Cells were treated with HU as indicated. Western blot analysis of total cell extracts was performed using antibody pS714. (C) Immunoprecipitation of endogenous hEXO1 from HEK-293T cells using either pS714 antibody (upper panel) or rabbit polyclonal antibody F-15 (lower panel) followed by western blot analysis with mouse monoclonal antibody Ab-4. (D) HEK-293T cells were transfected with an expression vector for wild-type Omni-hEXO1 (lanes 1-3). Cells were left untreated or treated with IR (10 Gy) or HU (2 mM), as indicated, and hEXO1 was immunoprecipitated using rabbit polyclonal antibody F-15 (upper panels). The signal given by IgG(H) was used as control for the quality of the immunoprecipitation. The phosphorylation status of hEXO1 and CHK2 was monitored by western blot analysis using phospho-specific antibodies (lower panels). TFIIH was used as loading control.
###end p 50
###begin p 51
###xml 32 35 32 35 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 47 48 47 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 317 320 317 320 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 498 499 498 499 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 661 664 661 664 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 792 795 792 795 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 798 799 798 799 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 876 879 876 879 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 1024 1025 1024 1025 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 369 374 <span type="species:ncbi:10090">mouse</span>
###xml 906 912 <span type="species:ncbi:9986">rabbit</span>
###xml 991 996 <span type="species:ncbi:10090">mouse</span>
###xml 1243 1249 <span type="species:ncbi:9986">rabbit</span>
Characterization of the hEXO1-pS714 antibody. (A) HeLa cells were transfected with EV (lane 1) or Omni-hEXO1 expression vector (lanes 2 and 3). Cells were left untreated or treated with HU for 24 h. Whole cell extracts were subjected to 8% SDS-PAGE electrophoresis, followed by western blot analysis using antibody pS714 to detect phosphorylated hEXO1 (upper panel) or mouse monoclonal antibody Ab-4 to visualize the entire pool of hEXO1 (middle panel). TFIIH served as control for equal loading. (B) HEK-293T cells were transfected with EV (lane 1), expression vector for wild-type Omni-hEXO1 (lanes 2 and 3) or for the non-phosphorylatable mutant Omni-hEXO1-A714 (lane 4). Cells were treated with HU as indicated. Western blot analysis of total cell extracts was performed using antibody pS714. (C) Immunoprecipitation of endogenous hEXO1 from HEK-293T cells using either pS714 antibody (upper panel) or rabbit polyclonal antibody F-15 (lower panel) followed by western blot analysis with mouse monoclonal antibody Ab-4. (D) HEK-293T cells were transfected with an expression vector for wild-type Omni-hEXO1 (lanes 1-3). Cells were left untreated or treated with IR (10 Gy) or HU (2 mM), as indicated, and hEXO1 was immunoprecipitated using rabbit polyclonal antibody F-15 (upper panels). The signal given by IgG(H) was used as control for the quality of the immunoprecipitation. The phosphorylation status of hEXO1 and CHK2 was monitored by western blot analysis using phospho-specific antibodies (lower panels). TFIIH was used as loading control.
###end p 51
###begin p 52
###xml 81 84 81 84 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 141 144 141 144 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 256 259 256 259 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 361 369 361 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 396 399 396 399 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 414 422 414 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 472 475 472 475 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 536 539 536 539 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
To definitely assess whether the epitope recognized by the antibody was phospho-S714, we ectopically expressed wt-hEXO1 or the point mutant A714-hEXO1 in HEK293 cells that were either left untreated or treated with HU. The results obtained show that the pS714 antibody could detect the HU-induced increase in hEXO1 phosphorylation only in the case of wt-hEXO1 (Figure 3B, lane 3) but not in the A714 point mutant (Figure 3B, lane 4). This allowed us concluding that the pS714 antibody specifically reacted with hEXO1 phosphorylated at S714.
###end p 52
###begin p 53
###xml 39 42 39 42 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 195 198 195 198 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 209 217 209 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 250 258 250 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 305 308 305 308 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 445 453 445 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 603 611 603 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 731 733 731 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 747 750 747 750 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
Next, we examined the ability of the pS714 antibody to detect endogenous hEXO1. To this end, immunoprecipitation experiments were performed on total extracts of HEK-293T cells using either the pS714 antibody (Figure 3C, upper panel) or antibody F15 (Figure 3C, lower panel). The data show that antibody pS714 was able to precipitate the phosphorylated form of the endogenous hEXO1 protein and this occurred only in the case of HU-treated cells (Figure 3C, lanes 2 and 3). The fact that a higher amount of phosphorylated hEXO1 was precipitated from MG-132 treated cells in comparison to untreated cells (Figure 3C, upper panel, lane 3 versus lane 2), confirmed our early finding that hEXO1 degradation is phosphorylation-dependent (32). Antibody pS714 was also suitable for the detection of phosphorylated hEXO1 by western blot analysis upon immunoprecipitation of the endogenous protein. A weak but clear signal was observed upon treatment with HU and the proteasome inhibitor MG-132 to prevent hEXO1 degradation (Supplementary Figure 4).
###end p 53
###begin p 54
###xml 27 30 27 30 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 96 99 96 99 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 362 365 362 365 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 440 448 440 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 534 537 534 537 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 539 547 539 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
Finally, considering that S714 belongs to the S/T-Q type of DNA damage sites, we asked whether S714 is specifically phosphorylated upon replication fork stalling or if it is also targeted in response to other types of DNA damage. To this end, we treated HEK-293T cells ectopically expressing Omni-tagged hEXO1 with either IR or HU. Detection of hEXO1 with the pS714 antibody indicated that HU potently induced phosphorylation at this site (Figure 3D, lane 3), whereas the IR treatment was only minimally affecting phosphorylation at S714 (Figure 3D, lane 2).
###end p 54
###begin p 55
###xml 46 49 46 49 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 113 116 113 116 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 144 147 144 147 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 221 224 221 224 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 587 590 587 590 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
Taken together, these results show that the pS714 antibody is able to specifically recognize the phosphorylated S714 epitope in hEXO1 and that S714 is a site selectively targeted in response to stalled replication. The pS714 antibody may be potentially employed to monitor the flow of signal transduction events in studies on stalled DNA replication. A second foreseeable application for this tool is the identification of hEXO1 interacting proteins by means of combined immunoprecipitation/mass spectrometry under conditions of stalled DNA replication, when hEXO1 is phosphorylated at S714.
###end p 55
###begin title 56
Mutation of the sites of phosphorylation and effect on hEXO1 protein stability
###end title 56
###begin p 57
###xml 267 270 267 270 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">454</sub>
###xml 273 276 273 276 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">621</sub>
###xml 282 285 282 285 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 339 347 339 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 387 394 387 394 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">621,714</sub>
###xml 400 407 400 407 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">454,714</sub>
###xml 466 474 466 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 514 525 514 525 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">454,621,714</sub>
###xml 632 640 632 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 679 690 679 690 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">454,621,714</sub>
###xml 1180 1183 1180 1183 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 1208 1211 1208 1211 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">714</sub>
###xml 1330 1338 1330 1338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1419 1430 1419 1430 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">454,621,714</sub>
###xml 1778 1786 1774 1782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 2401 2410 2397 2406 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4.</label>
###xml 2463 2464 2459 2460 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 3018 3019 3014 3015 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2410 3180 2406 3176 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="58">Effect of HU on non-phosphorylatable hEXO1 mutants. (<bold>A</bold>) HeLa cells were transfected with an expression vector for wild-type Omni-hEXO1 or the single Ala point mutants indicated in the panel. Cells were left untreated or treated with HU for 24 h. Total cell extracts were analyzed by western blot using the Omni-probe antibody to detect the tagged hEXO1 protein. Data were quantified using ImageQuant 5.2 software (Amersham-Biosciences/GE-Healthcare). Percent degradation was calculated as the ratio between the amount of protein present in HU treated over untreated lanes. TFIIH was used for normalization. (<bold>B</bold>) Analysis of multiple hEXO1-Ala point mutants was performed as indicated above. The data shown in panels A and B represent one of three independent experiments.</p>
###xml 2410 3180 2406 3176 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="58">Effect of HU on non-phosphorylatable hEXO1 mutants. (<bold>A</bold>) HeLa cells were transfected with an expression vector for wild-type Omni-hEXO1 or the single Ala point mutants indicated in the panel. Cells were left untreated or treated with HU for 24 h. Total cell extracts were analyzed by western blot using the Omni-probe antibody to detect the tagged hEXO1 protein. Data were quantified using ImageQuant 5.2 software (Amersham-Biosciences/GE-Healthcare). Percent degradation was calculated as the ratio between the amount of protein present in HU treated over untreated lanes. TFIIH was used for normalization. (<bold>B</bold>) Analysis of multiple hEXO1-Ala point mutants was performed as indicated above. The data shown in panels A and B represent one of three independent experiments.</p></caption>
###xml 3180 3180 3176 3176 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm1052f4"/>
###xml 2401 3180 2397 3176 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F4" position="float"><label>Figure 4.</label><caption><p textid="58">Effect of HU on non-phosphorylatable hEXO1 mutants. (<bold>A</bold>) HeLa cells were transfected with an expression vector for wild-type Omni-hEXO1 or the single Ala point mutants indicated in the panel. Cells were left untreated or treated with HU for 24 h. Total cell extracts were analyzed by western blot using the Omni-probe antibody to detect the tagged hEXO1 protein. Data were quantified using ImageQuant 5.2 software (Amersham-Biosciences/GE-Healthcare). Percent degradation was calculated as the ratio between the amount of protein present in HU treated over untreated lanes. TFIIH was used for normalization. (<bold>B</bold>) Analysis of multiple hEXO1-Ala point mutants was performed as indicated above. The data shown in panels A and B represent one of three independent experiments.</p></caption><graphic xlink:href="gkm1052f4"/></fig>
In order to assess the impact of phosphorylation on hEXO1 protein stability, we generated single and multiple Alanine point mutants of the sites of phosphorylation and expressed them in HeLa cells. The data showed that single mutation of the three HU-induced sites (A454, A621 and A714) did not rescue hEXO1 degradation in response to HU (Figure 4A). Likewise, the double point mutants A621,714 and A454,714 were as sensitive as wild-type hEXO1 to the effect of HU (Figure 4B). On the contrary, the triple mutant A454,621,714 was expressed to an apparently higher level than wild-type hEXO1 and resulted to be less sensitive to HU (Figure 4B). The higher basal stability of the A454,621,714 mutant is unlikely to result from constitutively increased expression (i.e. transcription and translation) of this specific isoform as compared to other point mutants. Such increased stability rather reflects the fact that, although phosphorylation at the three HU-induced sites might be substoichiometric under basal conditions of cell growth, it is sufficient to trigger continuous degradation of hEXO1. Support to this view comes from the evidence that low level of phosphorylation at S714 was detected with the pS714 antibody in exponentially growing HEK-293T cells that were ectopically expressing hEXO1 but were not treated with HU (Figure 3B, upper panel, lane 2). As mentioned above, we observed that the triple mutant A454,621,714 displayed increased resistance to HU-induced degradation as compared to wt-hEXO1 (29.3 +/- 6.35% degradation for the triple mutant versus 53.7 +/- 10.69% for the wild type, Supplementary Figure 5). On the other hand, mutation of all sites in a S/T-Q cluster (Supplementary Figure 2), did not result in any significant rescue of hEXO1 degradation (Figure 4B). Taken together, these data indicate that the HU-induced phosphorylation of hEXO1 at the three residues described in this study facilitated the destabilization of the protein, though additional events may contribute to hEXO1 degradation in response to fork arrest. With regard to this point, it is worth considering the possibility that ATR-dependent phosphorylation of hEXO1 interacting partners, among which might be a specific E3-ligase for hEXO1, could be of key importance in the overall control of hEXO1 degradation in response to stalled replication. Future experiments will aim at clarifying this issue. Figure 4.Effect of HU on non-phosphorylatable hEXO1 mutants. (A) HeLa cells were transfected with an expression vector for wild-type Omni-hEXO1 or the single Ala point mutants indicated in the panel. Cells were left untreated or treated with HU for 24 h. Total cell extracts were analyzed by western blot using the Omni-probe antibody to detect the tagged hEXO1 protein. Data were quantified using ImageQuant 5.2 software (Amersham-Biosciences/GE-Healthcare). Percent degradation was calculated as the ratio between the amount of protein present in HU treated over untreated lanes. TFIIH was used for normalization. (B) Analysis of multiple hEXO1-Ala point mutants was performed as indicated above. The data shown in panels A and B represent one of three independent experiments.
###end p 57
###begin p 58
###xml 53 54 53 54 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 608 609 608 609 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
Effect of HU on non-phosphorylatable hEXO1 mutants. (A) HeLa cells were transfected with an expression vector for wild-type Omni-hEXO1 or the single Ala point mutants indicated in the panel. Cells were left untreated or treated with HU for 24 h. Total cell extracts were analyzed by western blot using the Omni-probe antibody to detect the tagged hEXO1 protein. Data were quantified using ImageQuant 5.2 software (Amersham-Biosciences/GE-Healthcare). Percent degradation was calculated as the ratio between the amount of protein present in HU treated over untreated lanes. TFIIH was used for normalization. (B) Analysis of multiple hEXO1-Ala point mutants was performed as indicated above. The data shown in panels A and B represent one of three independent experiments.
###end p 58
###begin title 59
SUPPLEMENTARY DATA
###end title 59
###begin p 60
Supplementary Data are available at NAR Online.
###end p 60
###begin title 61
Supplementary Material
###end title 61
###begin title 62
[Supplementary Data]
###end title 62
###begin title 63
ACKNOWLEDGEMENTS
###end title 63
###begin p 64
We are indebted to C.M. Azzalin and J. Lengner (ISREC, Lausanne, Switzerland) for providing shRNA constructs, KUDOS Pharmaceuticals (Cambridge, UK) for supplying the ATM inhibitor KU-55933 and M. O'Driscoll and P. Jeggo, University of Sussex, UK for providing Seckel cells. We would like to thank members of S.F. laboratory for helpful suggestions. M.E.-S. was supported by a Swiss National Science Foundation grant (31-100090/1) and by a grant from the Sassella-Foundation, Zurich, Switzerland to S.F. We are also indebted to the Desiree and Niels Yde Foundation and the Ida De Pottere-Leupold-Fonds for generous financial support. Funding to pay the Open Access publication charges for this article was provided by Swiss National Science Foundation.
###end p 64
###begin p 65
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 65
###begin title 66
REFERENCES
###end title 66
###begin article-title 67
###xml 44 69 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
A DNA exonuclease induced during meiosis of Schizosaccharomyces pombe
###end article-title 67
###begin article-title 68
###xml 79 103 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Exo1 roles for repair of DNA double-strand breaks and meiotic crossing over in Saccharomyces cerevisiae
###end article-title 68
###begin article-title 69
Tosca: a Drosophila gene encoding a nuclease specifically expressed in the female germline
###end article-title 69
###begin article-title 70
###xml 30 35 <span type="species:ncbi:10090">mouse</span>
Expression specificity of the mouse exonuclease 1 (mExo1) gene
###end article-title 70
###begin article-title 71
###xml 20 25 <span type="species:ncbi:9606">human</span>
###xml 55 79 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Identification of a human gene encoding a homologue of Saccharomyces cerevisiae EXO1, an exonuclease implicated in mismatch repair and recombination
###end article-title 71
###begin article-title 72
###xml 39 63 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Identification and characterization of Saccharomyces cerevisiae EXO1, a gene encoding an exonuclease that interacts with MSH2
###end article-title 72
###begin article-title 73
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 49 54 <span type="species:ncbi:4932">yeast</span>
Human exonuclease 1 functionally complements its yeast homologues in DNA recombination, RNA primer removal, and mutation avoidance
###end article-title 73
###begin article-title 74
###xml 82 87 <span type="species:ncbi:4932">yeast</span>
Identification of factors interacting with hMSH2 in the fetal liver utilizing the yeast two-hybrid system. In vivo interaction through the C-terminal domains of hEXO1 and hMSH2 and comparative expression analysis
###end article-title 74
###begin article-title 75
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 63 68 <span type="species:ncbi:4932">yeast</span>
Hex1: a new human Rad2 nuclease family member with homology to yeast exonuclease 1
###end article-title 75
###begin article-title 76
###xml 19 24 <span type="species:ncbi:9606">human</span>
The RAD2 domain of human exonuclease 1 exhibits 5' to 3' exonuclease and flap structure-specific endonuclease activities
###end article-title 76
###begin article-title 77
###xml 30 38 <span type="species:ncbi:4896">S. pombe</span>
A role for exonuclease I from S. pombe in mutation avoidance and mismatch correction
###end article-title 77
###begin article-title 78
Hereditary colorectal cancer
###end article-title 78
###begin article-title 79
###xml 54 78 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Interactions of Exo1p with components of MutLalpha in Saccharomyces cerevisiae
###end article-title 79
###begin article-title 80
exo1-Dependent mutator mutations: model system for studying functional interactions in mismatch repair
###end article-title 80
###begin article-title 81
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human exonuclease I interacts with the mismatch repair protein hMSH2
###end article-title 81
###begin article-title 82
###xml 53 58 <span type="species:ncbi:9606">human</span>
The interaction of DNA mismatch repair proteins with human exonuclease I
###end article-title 82
###begin article-title 83
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human exonuclease I is required for 5' and 3' mismatch repair
###end article-title 83
###begin article-title 84
###xml 37 42 <span type="species:ncbi:9606">human</span>
Mechanism of 5'-directed excision in human mismatch repair
###end article-title 84
###begin article-title 85
###xml 10 15 <span type="species:ncbi:9606">human</span>
A defined human system that supports bidirectional mismatch-provoked excision
###end article-title 85
###begin article-title 86
###xml 41 46 <span type="species:ncbi:9606">human</span>
Endonucleolytic function of MutLalpha in human mismatch repair
###end article-title 86
###begin article-title 87
###xml 17 41 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Exonuclease I of Saccharomyces cerevisiae functions in mitotic recombination in vivo and in vitro
###end article-title 87
###begin article-title 88
###xml 123 128 <span type="species:ncbi:4932">yeast</span>
EXO1-dependent single-stranded DNA at telomeres activates subsets of DNA damage and spindle checkpoint pathways in budding yeast yku70Delta mutants
###end article-title 88
###begin article-title 89
###xml 62 67 <span type="species:ncbi:9606">human</span>
The exonucleolytic and endonucleolytic cleavage activities of human exonuclease 1 are stimulated by an interaction with the carboxyl-terminal region of the Werner syndrome protein
###end article-title 89
###begin article-title 90
###xml 30 35 <span type="species:ncbi:9606">human</span>
RECQ1 helicase interacts with human mismatch repair factors that regulate genetic recombination
###end article-title 90
###begin article-title 91
EXO1-A multi-tasking eukaryotic nuclease
###end article-title 91
###begin article-title 92
###xml 20 25 <span type="species:ncbi:9606">human</span>
Characterization of human exonuclease 1 in complex with mismatch repair proteins, subcellular localization and association with PCNA
###end article-title 92
###begin article-title 93
###xml 24 29 <span type="species:ncbi:9606">human</span>
Nuclear localization of human DNA mismatch repair protein exonuclease 1 (hEXO1)
###end article-title 93
###begin article-title 94
###xml 33 37 <span type="species:ncbi:10090">mice</span>
Inactivation of Exonuclease 1 in mice results in DNA mismatch repair defects, increased cancer susceptibility, and male and female sterility
###end article-title 94
###begin article-title 95
###xml 93 97 <span type="species:ncbi:10090">mice</span>
Altered somatic hypermutation and reduced class-switch recombination in exonuclease 1-mutant mice
###end article-title 95
###begin article-title 96
Fork reversal and ssDNA accumulation at stalled replication forks owing to checkpoint defects
###end article-title 96
###begin article-title 97
Exo1 processes stalled replication forks and counteracts fork reversal in checkpoint-defective cells
###end article-title 97
###begin article-title 98
###xml 15 20 <span type="species:ncbi:9606">human</span>
Degradation of human exonuclease 1b upon DNA synthesis inhibition
###end article-title 98
###begin article-title 99
Recombinant ATM protein complements the cellular A-T phenotype
###end article-title 99
###begin article-title 100
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human RNA surveillance factor UPF1 is required for S phase progression and genome stability
###end article-title 100
###begin article-title 101
Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels
###end article-title 101
###begin article-title 102
Automated identification of amino acid sequence variations in proteins by HPLC/microspray tandem mass spectrometry
###end article-title 102
###begin article-title 103
Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM
###end article-title 103
###begin article-title 104
ATR-dependent phosphorylation and activation of ATM in response to UV treatment or replication fork stalling
###end article-title 104
###begin article-title 105
Rapid activation of ATR by ionizing radiation requires ATM and Mre11
###end article-title 105
###begin article-title 106
A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome
###end article-title 106
###begin article-title 107
Large-scale characterization of HeLa cell nuclear phosphoproteins
###end article-title 107
###begin article-title 108
ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage
###end article-title 108

